{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:09:44Z","timestamp":1789016984211,"version":"build-2803163510"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Thoracic radiotherapy is integral to multimodal treatment for malignancies involving the thorax, but the literature on the burden of reported atrial fibrillation (AF) after thoracic radiotherapy and its relationship with cardiac substructure dose exposure has not been systematically synthesized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, Embase, the Cochrane Library, and Web of Science through May 17, 2026, for studies that reported AF incidence or comparative\/dosimetric associations among adults receiving thoracic radiotherapy for malignancies. Pooled incidence was estimated using logit-transformed random-effects proportion meta-analysis. Because cardiac structures, dose metrics, cutoffs, statistical models, and AF definitions differed across studies, dosimetric evidence was summarized using structured tables and evidence plots.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ten studies were included. Eight studies contributed nine cohort-level estimates to the incidence synthesis, including 3,192 patients, of whom 293 developed study-defined reported AF. The pooled incidence across all eligible cohorts was 9.1% (95% confidence interval (CI), 6.3%\u201312.9%; I\u00b2=90.0%; prediction interval, 2.5%\u201328.5%). After the exclusion of two esophageal cancer cohorts with substantial perioperative confounding, the main analysis included seven cohorts with a total of 2,766 patients, among whom 217 developed reported AF; the pooled incidence was 7.6% (95% CI, 5.6%\u201310.3%; I\u00b2=80.3%; prediction interval, 2.9%\u201318.8%). Nine reports described associations between cardiac or cardiac substructure radiation doses and AF risk. Adjusted findings suggested candidate signals involving the pulmonary veins, atria, sinoatrial node, and selected whole-heart dose metrics, although the findings were heterogeneous and unsuitable for quantitative pooling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Study-defined reported AF after thoracic radiotherapy represents a clinically relevant burden. Current evidence suggests candidate dosimetric regions involving the pulmonary veins, atria, and sinoatrial node, with selected whole-heart metrics showing signals. However, the evidence remains insufficient to support causal inference or clinical dose constraints. Prospective multicenter studies using standardized AF definitions, cardiac substructure delineation, and individual-patient data are needed to validate these signals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1910673","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:28:54Z","timestamp":1789014534000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations between reported atrial fibrillation burden and cardiac substructure dosimetric variables in patients receiving thoracic radiotherapy for malignancies involving the thorax: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Rui","family":"Li","sequence":"first","affiliation":[{"name":"Department of Oncology, The People\u2019s Hospital of Rongchang District","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingkai","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The People\u2019s Hospital of Rongchang District","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The People\u2019s Hospital of Rongchang District","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nengping","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The People\u2019s Hospital of Rongchang District","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology, The People\u2019s Hospital of Rongchang District","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The People\u2019s Hospital of Rongchang District","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The People\u2019s Hospital of Rongchang District","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The People\u2019s Hospital of Rongchang District","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The People\u2019s Hospital of Rongchang District","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The People\u2019s Hospital of Rongchang District","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71207-0","article-title":"Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1200\/JCO.20.03614","article-title":"Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: The randomized controlled CROSS trial","volume":"39","author":"Eyck","year":"2021","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.2373","article-title":"Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: The NEOCRTEC5010 randomized clinical trial","volume":"156","author":"Yang","year":"2021","journal-title":"JAMA Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/heartjnl-2024-325179","article-title":"Cardiovascular morbidity and mortality after radiotherapy for breast cancer: a systematic review and meta-analysis","volume":"112","author":"Yang","year":"2025","journal-title":"Heart"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2340\/1651-226X.2024.19677","article-title":"Doses to the right coronary artery and the left anterior descending coronary artery and death from ischemic heart disease after breast cancer radiotherapy: a case-control study in a population-based cohort","volume":"63","author":"Perman","year":"2024","journal-title":"Acta Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2023.11.029","article-title":"The association of incidental radiation dose to the heart base with overall survival and cardiac events after curative-intent radiotherapy for non-small cell lung cancer: Results from the NI-HEART study","volume":"36","author":"Walls","year":"2024","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"B9","first-page":"331","article-title":"Cardiac substructure analysis of radiation-associated cardiac disease in thoracic malignancy patients","volume":"11","author":"Heller","year":"2025","journal-title":"J Oncol Transl Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2026.111436","article-title":"Association between radiation dose to pulmonary vein substructures and post-treatment atrial fibrillation following neoadjuvant chemoradiotherapy for esophageal squamous cell cancer","volume":"217","author":"Huang","year":"2026","journal-title":"Radiother Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2340\/1651-226X.2026.43885","article-title":"The association of right atrium and sinoatrial node irradiation with atrial fibrillation and radiation-induced heart disease in non-small cell lung cancer","volume":"65","author":"Sander Graven-Nielsen","year":"2026","journal-title":"Acta Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71610","article-title":"Whole heart dose parameters predict severe arrhythmias after neoadjuvant chemoradiotherapy for esophageal squamous cell cancer: a competing risk analysis of 358 patients","volume":"15","author":"Qi","year":"2026","journal-title":"Cancer Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110544","article-title":"Prediction of new-onset atrial fibrillation in patients with non-small cell lung cancer treated with curative-intent conventional radiotherapy","volume":"201","author":"Tohidinezhad","year":"2024","journal-title":"Radiother Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2024.08.007","article-title":"Predictors of atrial fibrillation after thoracic radiotherapy","volume":"6","author":"Butler","year":"2024","journal-title":"JACC CardioOncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2024.07.005","article-title":"Cardiac substructure radiation dose and associations with tachyarrhythmia and bradyarrhythmia after lung cancer radiotherapy","volume":"6","author":"Atkins","year":"2024","journal-title":"JACC CardioOncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110241","article-title":"Risk of clinically significant cardiovascular disease associated with postoperative radiotherapy in non-small cell lung cancer patients receiving surgical resection followed by adjuvant chemotherapy: a Korean nationwide cohort study","volume":"195","author":"Kwon","year":"2024","journal-title":"Radiother Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.08.011","article-title":"Incident atrial fibrillation and survival outcomes in esophageal cancer following radiotherapy","volume":"118","author":"Miller","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.4202","article-title":"Association of sinoatrial node radiation dose with atrial fibrillation and mortality in patients with lung cancer","volume":"8","author":"Kim","year":"2022","journal-title":"JAMA Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110085","article-title":"Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: an NI-HEART analysis","volume":"192","author":"Walls","year":"2024","journal-title":"Radiother Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae043","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"26","author":"Tzeis","year":"2024","journal-title":"Europace"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae204","article-title":"Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)","volume":"26","author":"Goette","year":"2024","journal-title":"Europace"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010209","article-title":"Atrial fibrosis in atrial fibrillation: mechanistic insights, diagnostic challenges, and emerging therapeutic targets","volume":"26","author":"Karakasis","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/1754-9485.13716","article-title":"A roadmap for modelling radiation-induced cardiac disease","volume":"68","author":"Zhang","year":"2024","journal-title":"J Med Imaging Radiat Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02888-0","article-title":"Cardiotoxicity following thoracic radiotherapy for lung cancer","volume":"132","author":"Walls","year":"2025","journal-title":"Br J Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-024-01056-4","article-title":"Consequences of ionizing radiation exposure to the cardiovascular system","volume":"21","author":"Jahng","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/1754-9485.13737","article-title":"Moving beyond mean heart dose: the importance of cardiac substructures in radiation therapy toxicity","volume":"68","author":"Bowen Jones","year":"2024","journal-title":"J Med Imaging Radiat Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2021.02.002","article-title":"A radiation therapy contouring atlas for cardiac conduction node delineation","volume":"11","author":"Loap","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109680","article-title":"A pulmonary vein atlas for radiotherapy planning","volume":"184","author":"Walls","year":"2023","journal-title":"Radiother Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000986","article-title":"Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology: a scientific statement from the American Heart Association","volume":"144","author":"Fradley","year":"2021","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2024.07.017","article-title":"Cardiovascular considerations before cancer therapy: gaps in evidence and JACC: CardioOncology expert panel recommendations","volume":"6","author":"Raisi-Estabragh","year":"2024","journal-title":"JACC CardioOncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2024.06.005","article-title":"Cardiovascular considerations during cancer therapy: gaps in evidence and JACC: CardioOncology expert panel recommendations","volume":"6","author":"Leong","year":"2024","journal-title":"JACC CardioOncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaccao.2024.06.006","article-title":"Cardiovascular considerations after cancer therapy: gaps in evidence and JACC: CardioOncology expert panel recommendations","volume":"7","author":"Blaes","year":"2025","journal-title":"JACC CardioOncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-00761-6","article-title":"Early cardio-oncology intervention in thoracic radiotherapy: prospective single-arm pilot study","volume":"5","author":"Zhang","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2196\/67875","article-title":"Screening and risk analysis of atrial fibrillation after radiotherapy for breast cancer: protocol for the cross-sectional cohort study \"Watch Your Heart (WATCH)\"","volume":"14","author":"Saint-Lary","year":"2025","journal-title":"JMIR Res Protoc"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1910673\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:28:56Z","timestamp":1789014536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1910673\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":39,"alternative-id":["10.3389\/fonc.2026.1910673"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1910673","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1910673"}}